Dry Eye Syndromes: all 1,325 studies
Page 13 of 14. Open to participants first (193), then studies with results posted, then the rest; newest registration first within each.
- Evaluating Safety and Efficacy of FID 112903 Post Discontinuation of Long-term Use of RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05%CompletedNCT01198782Phase 4
- Salivary Gland Transplantation in the Treatment of Dry Eye in Patients With Stevens-Johnson Syndrome.CompletedNCT01178242Not applicable
- TearLab Refractive Surgery Dry Eye StudyCompletedNCT01176045
- An Evaluation of the Nighttime Retention of Effect of an Investigational Lubricant Eye Drop (FID 115958D)CompletedNCT01165164Not applicable
- Phase I Study to Evaluate the Tolerability of Eye Drop DA-6034 in Healthy VolunteersCompletedNCT01162954Phase 1
- To Evaluate the Physical Effects of Systane(R) Lubricant Eye Drops Compared to Refresh Tears(R) Lubricant Eye DropsCompletedNCT01160133Not applicable
- An Evaluation of the Daytime Use of an Investigational Lubricant Eye DropCompletedNCT01139372Not applicable
- Safety and Efficacy Study of EGP-437 (Dexamethasone Phosphate Formulated for Ocular Iontophoresis) to Treat Dry EyeCompletedNCT01129856Phase 3
- Corneal Epitheliotropic Factors in Autologous Serum Eye Drops in Nonautoimmune and Stevens-Johnson Syndrome With Dry EyeStatus unknownNCT01122303
- Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye PatientsCompletedNCT01118754Phase 1/2
- Efficacy of Systane Ultra in Post Menopausal Women With Dry EyeCompletedNCT01105910Phase 4
- A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Rewetting Drops in Subjects With History and Current Complaint of Contact Lens-Related Dry Eye (CLDE)CompletedNCT01105624Phase 4
- Acupuncture for Dry EyeCompletedNCT01105221Phase 3
- Study of DE-089 Ophthalmic Solution in Patients With Dry EyeCompletedNCT01101984Not applicable
- Efficacy of Systane Balance to Stabilize the Tear Film in Dry Eye SubjectsCompletedNCT01086774Phase 4
- Acute Comfort and Blur Profile of a Lubricant Eye Drop Versus a Marketed Lubricant Eye GelCompletedNCT01077011Not applicable
- Acute Comfort and Blur Profile of a Lubricant Eye Drop Versus a Marketed Eye OintmentCompletedNCT01076998Not applicable
- Evaluation of an Investigational Lubricant Eye Drop on Lipid Layer ThicknessCompletedNCT01066988Not applicable
- A Clinical Evaluation Pilot Study of the Efficacy of Blink® Tears Lubricant Eye Drops for the Relief of Dry Eye Symptoms Following Implantation of Tecnis® Multifocal Introcular LensCompletedNCT01061268Phase 4
- Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Subjects With Dry Eye - Effects on Central CorneaCompletedNCT01057147Phase 2
- Evaluation of the Repeated Usage of Systane Ultra EyedropCompletedNCT01051804Phase 4
- An Evaluation of the Safety and Efficacy of FID 114657CompletedNCT01030237Not applicable
- Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Patients With Dry EyeCompletedNCT01027013Phase 2
- Tear Film Break-Up Time Evaluation of FID 114657CompletedNCT01023464Not applicable
- Prospective Health Assessment of Cataract Patients' Ocular SurfaceCompletedNCT01016405
- Safety and Tolerability of Chitosan-N-acetylcysteine Eye Drops in Healthy Young VolunteersCompletedNCT01015209Phase 1
- Tear Film Thickness Measured Using a Novel TechniqueCompletedNCT01014780
- A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Dry Eye DiseaseCompletedNCT01014078Phase 4
- Clinical Evaluation of the Causes of Contact Lens Related Dry EyeCompletedNCT00995189Not applicable
- CXCL9, CXCL10, CXCL11, and CXCR3 in Dry Eye SyndromeCompletedNCT00991679
- Acute Comfort and Haze Profile of FID 114657CompletedNCT00983203Not applicable
- Barrier Function Measurement in Dry Eye Patients After Using Systane Ultra for 30 DaysCompletedNCT00946777Not applicable
- Evaluate the Ability of Systane Ultra to Improve Subjective Symptoms of Ocular Irritation Post 60 Min. Athletic Performance.CompletedNCT00938951Not applicable
- Efficacy Comparative Study Between Tears Again®, Opticol® and Optive®CompletedNCT00893243
- A Study of AL-38583 Ophthalmic Solution 0.05%, 0.010% Versus AL-38583 Vehicle for Dry EyeCompletedNCT00893139Phase 2
- Efficacy and Safety Study of Nutritional Supplements for Treatments of Dry EyeCompletedNCT00883649Not applicable
- A Dose-Escalation Study to Assess the Safety and Tolerability of LX214 Ophthalmic Solution in Healthy Volunteers, Followed by an Open-Label Evaluation of LX214 in Patients With Keratoconjunctivitis Sicca (KCS)CompletedNCT00851734Phase 1
- Evaluation of FID 114657 on Tear Film Lipid Layer ThicknessCompletedNCT00848068Not applicable
- A Study of Hydroxypropyl Guar Galactomannan 0.25% (HPGG) Versus Vehicle in Dry Eye PatientsCompletedNCT00840268Phase 2
- A Natural History Study of Patients With Dry EyeCompletedNCT00833235
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease (P08637)CompletedNCT00831662Phase 3
- Systane Clinical Experience StudyCompletedNCT00818909Phase 4
- A Dose-Ranging Clinical Study to Assess the Safety and Efficacy of Subconjunctival Injection of Sirolimus in Patients With Dry Eye in the Controlled Adverse Environmental (CAE) ModelCompletedNCT00814944Phase 2
- Double-Masked Trial of NOVA22007 (Ciclosporin 0.1%) Versus Vehicle in Patients With Moderate to Severe Dry Eye SyndromeCompletedNCT00814515Phase 3
- Tears Substitutions and Their Effects on Higher Order AberrometeryWithdrawnNCT00812721Not applicable
- Kynex Versus Refresh Plus Study in Subject With Dry EyeCompletedNCT00809198Phase 4
- Assessment of Inflammatory and Functional Changes in the Ocular Surface Associated With Dry Eye DiseaseCompletedNCT00809003
- Residence Time Evaluation of Marketed OTC Ophthalmic ProductsCompletedNCT00804791Not applicable
- Partial Lacrimal Punctual OcclusionCompletedNCT00802399Not applicable
- Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z®CompletedNCT00799682Phase 4
- Safety and Efficacy Study of RX-10045 on the Signs and Symptoms of Dry EyeCompletedNCT00799552Phase 2
- Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency VirusStatus unknownNCT00797030Phase 4
- Efficacy and Safety Study of ATs in Patients With Dry Eye SyndromeCompletedNCT00788229Phase 2
- A Prospective, Randomized, Double-Masked, Single Center, Clinical Comparison of the Use of Systane Ultra in the Management of Dry Eyes in Bilateral EyesCompletedNCT00781092Phase 4
- Autologous Serum Efficacy Study in Patients With Severe Dry EyeCompletedNCT00779987Phase 2
- A 2-week Clinical Comparison of SYSTANE® Ultra to Sensitive Eyes Rewetting Drops in Contact Lens Wearing Patients.CompletedNCT00769665
- Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Dry EyeCompletedNCT00765804Phase 2
- Diagnostic Evaluation of the Tear FilmCompletedNCT00761917
- Clinical Pharmacological Study of AL-43546 Ophthalmic Product in Subjects With Shortened Tear Film Break Up TimeCompletedNCT00760045Phase 2
- Effects of Sea Buckthorn Oil on Dry EyeCompletedNCT00739713Not applicable
- NOVA22007 0.05% and 0.1% Cyclosporine Versus Vehicle for the Treatment of Dry EyeCompletedNCT00739349Phase 2
- Lid Margin And Conjunctival Microbial Flora Following Punctum OcclusionCompletedNCT00735865Not applicable
- Evaluate Artificial Tear Efficacy in Moderate to Severe Dry EyeCompletedNCT00724412Phase 4
- Phase 2 Study of KLS-0611 in Patients With Dry Eye SyndromesCompletedNCT00721656Phase 2
- The Evaluation of Thiol Redox Status in Conjunctiva of Dry Eye PatientsStatus unknownNCT00718926
- Tear Dynamics After Restasis Treatment in Dry Eye PatientsCompletedNCT00706940
- Comparison of Efficacy, Safety and Anti-Inflammatory Effect Between Topical 0.05%Cyclosporine A Emulsion and REFRESH® in Patients With Moderate to Severe Dry EyesStatus unknownNCT00704275Phase 4
- A Study to Determine the Safety and Tolerability of Escalating Doses of INS365 Ophthalmic SolutionCompletedNCT00680108Phase 2
- A Study of INS365 Ophthalmic Solution in Patients With Moderate to Severe Dry Eye DiseaseCompletedNCT00679718Phase 2
- Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual QualityCompletedNCT00622037Phase 4
- Bilateral, Masked Comparison of PEG-400 Based Artificial Tear vs. Systane for Dry Eye Signs, Symptoms & Refractive Regression Associated With Myopic Laser in Situ Keratomilieusis (LASIK).CompletedNCT00620893Phase 4
- Artificial Tears Study in Mild to Moderate Dry Eye PatientsCompletedNCT00607776Phase 2
- Study of the Effect of Diquafosol Tetrasodium Ophthalmic Solution, 2% Versus Placebo in Dry Eye Subjects (P08634)CompletedNCT00600288Phase 3
- Safety and Efficacy Assessment of Vismed® (Sodium Hyaluronate) for the Treatment of Dry Eye SyndromeCompletedNCT00599716Phase 3
- Objective Measurements of Prolonged Effects of Restasis on Dry Eye DiseaseCompletedNCT00567177Phase 4
- Loteprednol Etabonate Opthalmic Suspension for the Treatment of Dry EyeCompletedNCT00560638Phase 2
- Acupuncture Treatment of Dry EyeCompletedNCT00554879Not applicable
- The Relationship of Residence Time and Visual Effect of Optive and Systane in Dry Eye SubjectsCompletedNCT00553579
- Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006)CompletedNCT00549289Phase 3
- Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007)CompletedNCT00548301Phase 3
- Study to Assess the Safety and Patients' Satisfaction of Tears Again* in the Treatment of Dry Eye SymptomsCompletedNCT00535054Not applicable
- Biochemical Factors for a Dry Eyed PopulationCompletedNCT00522847
- Eye Drop Use in Glaucoma Patients Through Patient Surveys and Video ObservationsCompletedNCT00522600
- Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction PhaseCompletedNCT00520260Phase 4
- Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-005)CompletedNCT00502073Phase 3
- Cross-Over Evaluation of Two Lubricating Eye DropsCompletedNCT00493662Phase 4
- Oasys vs. Extreme H20 Xtra 59CompletedNCT00477763Phase 4
- Phase II Study of AL-2178 (FID 109980) in the Treatment of Dry EyeCompletedNCT00471419Phase 3
- Safety and Efficacy of Optive in Contact Lens Wearers With Dry EyesCompletedNCT00469573Phase 4
- Refractive Surgery and Optive Compatibility StudyCompletedNCT00469157Phase 4
- Comparison of Autologous Serum and Umbilical Cord Serum Eyedrops for Dry Eye SyndromeCompletedNCT00442273Not applicable
- A Study of ALTY-0501 for the Treatment of Dry Eye Administered 4 Times a Day for a 56 Day PeriodCompletedNCT00439400Phase 2
- Effect of B-cell Depletion in Patients With Primary Sjögren's SyndromeCompletedNCT00426543Phase 2
- Goblet Cell Response and Dry Eye Symptoms After PRK and LASIKCompletedNCT00411827Not applicable
- Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With RestasisCompletedNCT00407043Phase 4
- Comparison of Frequency of Use of Optive and SystaneCompletedNCT00406510Phase 4
- Efficacy and Safety of a New Multi-dose Lubricant Eye Drop Concomitant With Restasis® (Cyclosporine A) for the Treatment of Dry Eye SymptomsCompletedNCT00405457Phase 4
- Study of INS365 Ophthalmic Solution in Subjects With Dry Eye DiseaseCompletedNCT00404131Phase 3
- Study of Diquafosol Tetrasodium Ophthalmic Solution in Subjects With Dry Eye DiseaseCompletedNCT00403975Phase 3
- Study of INS365 Ophthalmic Solution in Subjects With Dry Eye DiseaseCompletedNCT00403715Phase 3